Bruker Corporation has grown revenue 8.8% a year over three years and 9.1% a year over five. Revenue growth, 3-year annual rate: +8.8% (Medical Devices median +12%). Revenue growth, 5-year rate: +9.1%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

BRKRBruker Corporation

Healthcare

$58.83+78% 1Y

$58.83

$30.6852 weeks$64.74

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−6.4 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +9% a year.

Margin direction−6.4 points operating

Trailing-twelve-month operating margin, -1.2% now against 5.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BRKR growing?

Bruker Corporation has grown revenue 8.8% a year over three years and 9.1% a year over five.

+8.8%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.1%
Revenue growth, 5-year rate · +8.8% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›